#406: More Nuanced Clinical Outcomes from Person-Generated Health Data: The New Frontier
Thursday, June 20, 2024 8:00 AM to 9:00 AM · 1 hr. (US/Pacific)
Room 6B
05: Patient-Focused Drug Dev09: Regulatory
Information
Person-generated data offers nuanced effectiveness measures for clinical and regulatory decision-making for new medical products, like the wearable-derived digital clinical outcome assessment for Duchenne muscular dystrophy. What's next?
CE
ACPECMERN
Session Level
Basic
Featured Topics
Patient Focused
Speakers

Paul Strijbos
Senior Principal Neurotech Innovation LeaderF. Hoffmann-La Roche LtdJS
Jeffrey Siegel
Director, Office of Drug Evaluation Sciences, OND, CDERFDA
Christina Mack
Chief Scientific Officer, Real-World SolutionsIQVIAMA
Martha Azer
Associate Director, Global Regulatory Policy & IntelligenceJohnson & Johnson
Nancy Dreyer
FounderDreyer Strategies LLC